As of September 29, 2026, Telix Pharmaceuticals's top three insider holders are Christian Behrenbruch (Md Group Ceo, 20.74Mn shares), Darren Charlton Smith (Group Chief Financial Officer, 13.99K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Christian Behrenbruch | Md Group Ceo | 0 | 20,742,935 | 20,742,935 | 99.9% | 06 May, 2026 |
| 2 | Darren Charlton Smith | Group Chief Financial Officer | 13,992 | 0 | 13,992 | 0.1% | 14 Sep, 2026 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 28 Apr, 2026 | Christian Behrenbruch | Md Group Ceo | Acquired P | 34,500 | $14.48 | $499.56K | 20,709,500 | Indirect |
| 29 Apr, 2026 | Christian Behrenbruch | Md Group Ceo | Acquired P | 33,435 | $14.87 | $497.18K | 20,742,935 | Indirect |
| 29 Mar, 2026 | Darren Charlton Smith | Group Chief Financial Officer | Acquired M | 1,111 | $0.00 | $0 | 11,921 | Direct |
| 29 Mar, 2026 | Darren Charlton Smith | Group Chief Financial Officer | Disposed M | 1,111 | $0.00 | $0 | 0 | Direct |